IE32197L - Pharmceutical composition - Google Patents
Pharmceutical compositionInfo
- Publication number
- IE32197L IE32197L IE83968A IE83968A IE32197L IE 32197 L IE32197 L IE 32197L IE 83968 A IE83968 A IE 83968A IE 83968 A IE83968 A IE 83968A IE 32197 L IE32197 L IE 32197L
- Authority
- IE
- Ireland
- Prior art keywords
- silver
- heavy metal
- july
- compositions
- metal salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1,240,546. Medicines containing antibiotics and sulphonamides. RESEARCH CORP. 16 July, 1968 [17 July, 1967], No. 49459/70. Divided out of 1,240,545. Heading A5B. A pharmaceutical composition comprises a heavy metal salt of an antibiotic in admixture with a heavy metal salt of a sulphonamide and/or silver salicylate. The heavy metal salts may be those of gold, nickel, tin, zinc, mercury, platinum, osmium, molybdenum, titanium, copper or silver (preferred). Specified are silver salts of penicillin, cephalothin, colistimethate, and tetracycline; and silver salts of sulphamerazine, sulphonanilide, sulphathiazole, sulphapyridine, sulphamylon, sulphoxazole, sulphapyrimidine, sulphaquinoxaline, substituted benzene sulphonamide and sulphamyl benzothiadiazine dioxide. The compositions may be in the form of a powder, an aqueous suspension, ointment, aerosol or may be incorporated in a film-forming material. Aqueous solutions containing chloride ions e.g. NaCl may be used as carriers for the active ingredients. Specification 1,240,545 is referred to. The compositions are useful in the treatment of burns.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE426/72A IE32198B1 (en) | 1967-07-17 | 1968-07-15 | Improvements in or relating to antibacterial compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65383067A | 1967-07-17 | 1967-07-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE32197L true IE32197L (en) | 1969-01-17 |
IE32197B1 IE32197B1 (en) | 1973-05-16 |
Family
ID=24622450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE83968A IE32197B1 (en) | 1967-07-17 | 1968-07-15 | Silver-containing therapeutic agents |
Country Status (8)
Country | Link |
---|---|
BE (1) | BE718183A (en) |
DE (1) | DE1792053B1 (en) |
ES (1) | ES356142A1 (en) |
FR (2) | FR1586125A (en) |
GB (2) | GB1240545A (en) |
IE (1) | IE32197B1 (en) |
NL (1) | NL6809794A (en) |
PH (1) | PH10639A (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4049802A (en) | 1975-03-19 | 1977-09-20 | Research Corporation | Zinc sulfadiazine and its use in the treatment of burns |
DE2804931A1 (en) * | 1978-02-06 | 1979-08-16 | Fresenius Chem Pharm Ind | METAL SULFADIAZINE IN FINE PARTICULAR FORM |
US4384117A (en) * | 1980-03-18 | 1983-05-17 | The United States Of America As Represented By The Secretary Of The Army | Silver metachloridine |
US4933330A (en) * | 1987-04-01 | 1990-06-12 | Dak-Laboratoriet | Benzoic acid derivatives and use thereof |
CA2024220A1 (en) * | 1990-08-29 | 1992-03-01 | Don Simmons | Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery |
IT1243435B (en) * | 1990-10-05 | 1994-06-10 | Altergon Sa | PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE INCLUDING HYALURONIC ACID SODIUM SALT AND DISINFECTANT SUBSTANCES |
US7074788B2 (en) | 2001-11-22 | 2006-07-11 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
WO2004103980A1 (en) * | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
US7173030B2 (en) | 2003-05-21 | 2007-02-06 | Biovitrum Ab | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
SE0301885D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use IV |
WO2004113310A1 (en) * | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
SE0301888D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use VII |
SE0301884D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use III |
SE0301886D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use V |
SE0301882D0 (en) * | 2003-06-25 | 2003-06-25 | Biovitrum Ab | New use I |
BRPI1104620B1 (en) * | 2011-09-09 | 2020-04-07 | Lucia Teixeira De Carvalho | pharmaceutical composition for the treatment of burns and skin lesions and their preparation process |
-
1968
- 1968-07-05 PH PH9358A patent/PH10639A/en unknown
- 1968-07-10 NL NL6809794A patent/NL6809794A/xx unknown
- 1968-07-13 ES ES356142A patent/ES356142A1/en not_active Expired
- 1968-07-15 IE IE83968A patent/IE32197B1/en unknown
- 1968-07-16 FR FR1586125D patent/FR1586125A/fr not_active Expired
- 1968-07-16 GB GB33831/68A patent/GB1240545A/en not_active Expired
- 1968-07-16 GB GB4945970A patent/GB1240546A/en not_active Expired
- 1968-07-17 BE BE718183D patent/BE718183A/xx not_active IP Right Cessation
- 1968-07-17 DE DE19681792053 patent/DE1792053B1/en active Pending
- 1968-10-11 FR FR169591A patent/FR8146M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PH10639A (en) | 1977-07-22 |
FR8146M (en) | 1970-08-17 |
DE1792053B1 (en) | 1971-07-29 |
FR1586125A (en) | 1970-02-13 |
NL6809794A (en) | 1969-01-21 |
GB1240545A (en) | 1971-07-28 |
ES356142A1 (en) | 1970-02-16 |
GB1240546A (en) | 1971-07-28 |
BE718183A (en) | 1969-01-17 |
IE32197B1 (en) | 1973-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR1586125A (en) | ||
GB1410588A (en) | Composition | |
ES475035A1 (en) | Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof | |
GB1385086A (en) | Insulin product | |
GB1397073A (en) | 1,2,4-oxadizoles | |
GB1442772A (en) | Inhibition of leukaemia utilizing 5-methyl-tetrahydrohomofolate | |
GB1419121A (en) | Heterocyclic-fused triazole derivatives and their use in controlling plant pathogenic organisms | |
GB1252286A (en) | ||
GB1361198A (en) | Disulphide compounds and process for their manufa'ture | |
GB1350878A (en) | Coumarin derivatives and production thereof | |
GB1512604A (en) | Pharmaceutical compositions | |
GB1276061A (en) | Tetronic acid derivatives, process for the manufacture thereof, and compositions containing such compounds | |
GB1314899A (en) | Thiosemicarbazones processes for their preparations and compositions incorporating them | |
ES431943A1 (en) | Cephalosporin derivatives | |
GB1324750A (en) | Diacetate pharmaceutical preparations and manufacturing processes | |
GB1252373A (en) | ||
GB1381072A (en) | 3-amino-as-triazino-6,5-quinoline and derivatives | |
GB1466857A (en) | Urea tablets | |
GB1287433A (en) | Pharmaceutical compositions | |
GB1214576A (en) | Complexes having a prolonged adrenocorticotropic activity and process for their manufacture | |
GB994350A (en) | Improvements in or relating to pteridine compounds and processes for their preparation | |
GB1175590A (en) | Therapeutic Compositions | |
GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
GB1230906A (en) | ||
GB1247347A (en) | Pyrimidine derivatives, the preparation thereof and compositions containing the same |